Answers are grounded in this paper and cite their sources.
Narrative review reveals how mitochondrial oxidative stress drives cellular damage in type 2 diabetes, highlighting mitochondria-targeted therapies to break this pathological cycle.
Type 2 diabetes mellitus has become one of the fastest-growing global health crises, affecting millions worldwide. This review explores the intricate relationship between mitochondrial dysfunction and oxidative stress in driving the development and progression of this metabolic disorder. Chronic high blood sugar levels trigger excessive production of reactive oxygen species from dysfunctional mitochondria, creating a destructive cycle that impairs insulin action, damages insulin-producing pancreatic cells, and fuels persistent low-grade inflammation. These interconnected pathological processes ultimately lead to the metabolic breakdown characteristic of type 2 diabetes. The review also examines emerging therapeutic strategies, including mitochondria-targeted antioxidants and lifestyle interventions that show promise in restoring cellular energy balance and breaking this harmful cycle.
No takes yet. Share an insight, caveat, or question.
Kumar* et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: